Clinical Development
Clinical development services for clinical trials in Australia.
Adelis Health designs and manages clinical development programs that generate the evidence required to progress healthcare innovations towards regulatory approval and commercialisation.
What We Deliver
Evidence-led clinical programs, managed from first patient to final report.
Our clinical development team works with innovators, researchers and organisations that need rigorous, well-run clinical trials in Australia. We structure each program around the product, its evidence requirements and its path to market.
Capabilities
End-to-end clinical development support.
The capabilities required to design, execute and conclude clinical development programs that stand up to regulatory and commercial scrutiny.
Protocol & Program Design
Designing clinical development programs that establish evidence, demonstrate product performance and support progression towards regulatory approval and commercialisation.
Trial Management
Coordinating study start-up, site selection, investigator engagement, patient recruitment and day-to-day trial operations to keep programs on track.
Regulatory & Ethics Navigation
Managing regulatory strategy, submissions and ethics approvals in Australia, aligning clinical data packages with TGA requirements and international standards.
Data, Quality & Compliance
Implementing data management, monitoring and quality frameworks that protect patient safety and preserve the integrity of clinical evidence.
Commercial Readiness
Bridging clinical outcomes with market entry by preparing the evidence, messaging and stakeholder materials needed for reimbursement, launch and adoption.
Where We Apply It
Clinical development across healthcare innovation.
Pharmaceuticals
Medical Devices
Diagnostics
Digital Health Products
Clinical Trials Australia
Why Australia for clinical development?
Australia offers a robust regulatory framework, experienced investigators and a cost-efficient environment for conducting clinical trials. These advantages make it a strong jurisdiction for generating high-quality evidence that supports both local and global market entry.
- Experienced clinical and research networks
- Clear regulatory and ethics pathways
- High-quality data accepted globally
- Efficient path from first-in-human to pivotal studies
Partnership Structures
Built around your innovation.
Adelis structures each commercial relationship around the innovation and the objectives of its owner, using royalties, equity or other structures as appropriate.
Ready to advance your clinical program?
Whether you need protocol design, trial management or an integrated clinical and commercialisation partner, we would like to understand what you are building.
Talk to Adelis